Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide
Open Access
- 20 December 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell & Bioscience
- Vol. 3 (1), 48
- https://doi.org/10.1186/2045-3701-3-48
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Targeted Coating With Antigenic Peptide Renders Tumor Cells Susceptible to CD8+ T Cell-mediated KillingMolecular Therapy, 2013
- Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+ T Cells in the Tumor Loci and Enhanced Anti-Tumor EffectsPLOS ONE, 2012
- Development of a syngeneic mouse model of epithelial ovarian cancerJournal of Ovarian Research, 2010
- NKG2D ligands in tumor immunityOncogene, 2008
- Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cellsGene Therapy, 2007
- Chimeric NK-receptor–bearing T cells mediate antitumor immunotherapyBlood, 2005
- MesothelinClinical Cancer Research, 2004
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003
- Elevated furin expression in aggressive human head and neck tumors and tumor cell linesMolecular Carcinogenesis, 2001
- fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas.JCI Insight, 1987